Fewer than 50% of clients at the UK's five largest veterinary groups knew their practice was part of a chain, according to the Competition and Markets Authority's review of the sector. Those same groups, CVS, IVC, Linnaeus, Medivet, VetPartners, averaged prices 18.3% above independents while scoring worse on client satisfaction with cost.
The mechanism that used to work
Historically, veterinary markets self-regulated through localized reputation. The vet was a known individual in your town whose livelihood depended on local word-of-mouth over a career. Word travels fast in a small market, and the vet bore the reputational cost personally, a strong incentive against overcharging or overtreating. That mechanism substituted for formal price regulation in professional-service markets for decades.
When ownership shifts to a private-equity-backed chain, that mechanism breaks down. Prices aren't always set locally. The trusted local clinic brand now sits inside a different ownership and incentive structure. Personal reputation diffuses across a corporation. The CMA found that trust in individual vet professionalism remains high across the board, but the market feature that made "trust the vet" work as a pricing check, localized reputation, got dismantled faster than any replacement emerged.
Our read: opacity isn't a side effect, it's load-bearing
We're reading the CMA data as a competition problem, not just a disclosure nicety. If clients don't know they're walking into a corporate-owned practice, they can't comparison-shop on that dimension, and they can't adjust their expectations about how pricing decisions get made. The premium pricing at corporate groups suggests that opacity props up pricing power: clients assume they're paying the local vet's rates when they're actually paying rates set by a portfolio company optimizing across dozens or hundreds of locations.
The CMA's reforms mandate ownership disclosure at the point of care. The bet: if clients know which practices are corporate-owned and which are independent, price competition can work again. We're skeptical. Mandated disclosure doesn't rebuild the career-long reputational stake a local vet used to carry, and it doesn't change the incentive structure inside a private-equity-backed group. It just gives clients one more piece of information to act on, if they choose to act on it.
We write one of these every week for people running practices or deciding whether to sell them. subscribe to VeterinaryPracticeNow.
What this means if you're weighing a sale
If brand opacity props up corporate pricing power, selling means betting your goodwill transfers invisibly to the acquirer and that regulatory scrutiny of the consolidation model stays light. The UK data suggests both assumptions are under pressure. Your local reputation was the asset; the question is whether it survives the transfer intact or whether clients start asking whose practice this actually is now.
If you're an associate at a corporate group, you're delivering care under a pricing structure clients don't understand and regulators are targeting. That misalignment lands on you at the exam table when the invoice prints and the client's face changes. The CMA found trust in individual vet professionalism remains high, but client satisfaction with cost scored worse at corporate groups despite premium pricing. You're absorbing the reputational cost of a pricing decision you didn't make.
If you own independently, the data hands you a differentiation argument if you choose to use it: known ownership, transparent pricing, measurably higher satisfaction on cost. The UK numbers suggest clients value that once they know the difference exists. Whether US clients ask the same questions depends on whether someone makes the comparison visible.
The mechanism that made this market self-regulating for decades was itself a market feature, localized reputation. Consolidation dismantled it faster than any replacement emerged.
What we're watching
Whether US regulators or state veterinary boards start asking the same questions the CMA asked: Do clients know who owns the practice? Do corporate-owned practices charge a premium? Does satisfaction track pricing? The UK had to run a formal competition review to surface those numbers. The US veterinary market is following the same consolidation trajectory without comparable transparency mandates. The data exists; the question is whether anyone with enforcement authority decides to pull it.